Market News AIOpen the app

TNGX stock news · Tango Therapeutics, Inc.

Stories about Tango Therapeutics, Inc. (TNGX) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for TNGX

Follow Tango Therapeutics, Inc. (TNGX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for TNGX
Free on the App Store and Google Play, or on the web.
  1. Nov 9, 2026, 7:23 AM ET · Market

    Tango Therapeutics shared its financial results and business updates for the quarter ending September 30, 2026.

    Neutral

    Tango filed an 8-K about a results release for the quarter ended September 30, 2026. The filing gives no figures showing whether the business improved or worsened, so it does not change the outlook.

  2. Oct 23, 2026, 1:44 PM ET · Market

    Big investors are making moves in 10 health care stocks today.

    Neutral

    The alert marked Tango Therapeutics' call trade bullish. It reports trading activity, not a company change, so it does not change the company's outlook.

  3. Oct 23, 2026, 8:20 AM ET · Market

    12 health care companies are changing a lot in Friday's early trading.

    Neutral

    Tango Therapeutics' shares fell about 13% to $24.26 in Friday's pre-market session. The report gives no company update, so the move alone does not change Tango Therapeutics' business outlook.

  4. Oct 23, 2026, 6:44 AM ET · Market

    Tango Therapeutics shares important news about its drug trial results.

    Good for TNGX

    Tango reported tumor responses with its drug combination and plans a larger study. The early results support a positive read, despite dose-related side effects.

  5. Sep 9, 2026, 10:16 AM ET · Market

    Caleres had a strong second quarter, and shares of Opus Genetics, Flotek Industries, and others also went up on Wednesday.

    Good for TNGX

    Tango Therapeutics’ shares climbed over 10% in the session, signaling positive sentiment.